Duodenal pH in health and duodenal ulcer disease: effect of a meal, Coca-Cola, smoking, and cimetidine.

Broad-spectrum antimicrobial activity of human intestinal defensin 5. Infect Immun (1997) 2.22

Technical aspects of intraluminal pH-metry in man: current status and recommendations. Gut (1987) 1.70

Duodenal ulcer pain--the role of acid and inflammation. Gut (1993) 0.98

Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man? Gut (1987) 0.97

The pathophysiology of peptic ulcer disease. Dig Dis Sci (1985) 0.96

Optimizing acid suppression for treatment of acid-related diseases. Dig Dis Sci (1995) 0.96

24-hour ambulatory dual gastroduodenal pH monitoring. The role of acid in duodenal ulcer disease. Ann Surg (1988) 0.92

Understanding soft drink consumption among male adolescents using the theory of planned behavior. J Behav Med (2004) 0.92

Sample taking problems in measuring actual histamine levels of human gastroduodenal mucosa: specific and general relevance in clinical trials on peptic ulcer pathogenesis and selective proximal vagotomy. Gut (1985) 0.85

''Sandwich'' treatment for diospyrobezoar intestinal obstruction: a case report. World J Gastroenterol (2014) 0.83

Buffer Therapy for Cancer. J Nutr Food Sci (2012) 0.81

Recent advances in the treatment of duodenal ulcer disease. A surgical perspective. West J Med (1987) 0.79

On the association between soft drink consumption and Helicobacter pylori infection. Dig Dis Sci (2011) 0.78

Prognosis of chronic duodenal ulcer: a prospective study of the effects of demographic and environmental factors and ulcer healing. Gut (1987) 0.76

A Multiphase Flow in the Antroduodenal Portion of the Gastrointestinal Tract: A Mathematical Model. Comput Math Methods Med (2016) 0.75

How does smoking harm the duodenum? Br Med J (Clin Res Ed) (1988) 0.75

Profile of pH, pressure, and potential difference at gastroduodenal junction in man. Gastroenterology (1965) 3.07

Levels of intragastric and intraduodenal acidity. Clin Sci (Lond) (1955) 2.07

Reduction of twenty-four-hour gastric acidity with combination drug therapy in patients with duodenal ulcer. Gastroenterology (1979) 1.98

Continuously recorded in situ pH of gastric and duodenal contents in patients with and without duodenal ulcers. Gastroenterology (1956) 1.67

pH of the contents of the duodenal bulb in relation to duodenal ulcer. Gut (1966) 1.57

Chronic disease in former college students; 13. Early precursors of peptic ulcer. Am J Epidemiol (1974) 1.40

Acidity at different sites in the proximal duodenum of normal subjects and patients with duodenal ulcer. Gut (1966) 1.40

In situ pH of duodenal bulb contents in normal and duodenal ulcer subjects. Gastroenterology (1967) 1.29

Serial pH changes in the duodenal bulb during smoking. Gastroenterology (1978) 1.28

Simultaneous measurement of basal pancreatic, gastric acid secretion, plasma gastrin, and secretin during smoking. Gastroenterology (1977) 1.20

Effect of cigarette smoking on gastric secretions of patients with duodenal ulcer. N Engl J Med (1956) 1.13

Effect of smoking on gastric secretion. Lancet (1959) 1.13

Inhibition of pancreatic secretion in man by cigarette smoking. Gut (1972) 1.11

Acid-base parameters of duodenal contents in man. Gastroenterology (1972) 1.05

HYDROGEN ION CONCENTRATION OF THE DUODENAL CONTENTS UNDER FASTING CONDITIONS IN NORMAL PERSONS AND IN PATIENTS WITH DUODENAL ULCER: A COMPARATIVE STUDY. J Clin Invest (1941) 1.03

Secretion pattern of secretin in man: regulation by gastric acid. Gut (1978) 1.02

Smoking and duodenal ulcer. Gastroenterology (1978) 1.01

Effects of cigarette smoking on bicarbonate and volume of duodenal contents. Am J Dig Dis (1973) 0.97

Duodenal pH values in normal controls and in patients with duodenal ulcer. Gut (1969) 0.95

Gastric acid regulates the release of plasma secretin in man. Eur J Clin Invest (1982) 0.93

Association between the occurrence of peptic ulcers and tobacco smoking. Public Health (1974) 0.88

A comparison of basal and stimulated gastric acid and duodenal bicarbonate in patients with and without duodenal ulcer disease. Am J Gastroenterol (1976) 0.84

Acid secretion in duodenal ulcer disease before and after surgery. Mt Sinai J Med (1975) 0.81

pH in the human duodenum. Its physiological and pathophysiological significance. Digestion (1973) 0.80

Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12

Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods. Gut (1995) 4.70

Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med (1995) 4.56

One week eradication regimen for Helicobacter pylori. Lancet (1991) 4.50

Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut (2010) 4.50

THE ANEMIA OF INFECTION. III. THE UPTAKE OF RADIO-ACTIVE IRON IN IRON-DEFICIENT AND IN PYRIDOXINE-DEFICIENT PIGS BEFORE AND AFTER ACUTE INFLAMMATION. J Clin Invest (1947) 3.73

Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet (2000) 3.52

Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. BMJ (1996) 3.33

Recommendations for standards of sedation and patient monitoring during gastrointestinal endoscopy. Gut (1991) 3.27

Guidelines on appropriate indications for upper gastrointestinal endoscopy. Working Party of the Joint Committee of the Royal College of Physicians of London, Royal College of Surgeons of England, Royal College of Anaesthetists, Association of Surgeons, the British Society of Gastroenterology, and the Thoracic Society of Great Britain. BMJ (1995) 3.25

MIST VR: a virtual reality trainer for laparoscopic surgery assesses performance. Ann R Coll Surg Engl (1997) 3.04

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med (2000) 2.78

Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut (1995) 2.20

A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease. Aliment Pharmacol Ther (2014) 2.18

Simplified single sample 13Carbon urea breath test for Helicobacter pylori: comparison with histology, culture, and ELISA serology. Gut (1991) 2.04

ABC of the upper gastrointestinal tract: Pathophysiology of duodenal and gastric ulcer and gastric cancer. BMJ (2001) 1.99

How to beautify your old hospital. Br Med J (Clin Res Ed) (1984) 1.95

Campylobacter pylori in esophagus, antrum, and duodenum. A histological and microbiological study. Dig Dis Sci (1989) 1.92

Anticoagulation control with warfarin by junior hospital doctors. J R Soc Med (1987) 1.90

Evidence for a complex regulating the in vivo activities of early enzymes induced by bacteriophage T4. J Biol Chem (1974) 1.87

Hypothesis: Helicobacter pylori, urease, mucus, and gastric ulcer. Lancet (1990) 1.85

A procedure-specific systematic review and consensus recommendations for postoperative analgesia following laparoscopic cholecystectomy. Surg Endosc (2005) 1.75

Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut (1994) 1.75

Rapid diagnosis of Campylobacter pyloridis infection. J Clin Pathol (1987) 1.74

Histological identification of Campylobacter using Gimenez technique in gastric antral mucosa. J Clin Pathol (1987) 1.72

Characteristics of the deo operon: role in thymine utilization and sensitivity to deoxyribonucleosides. J Bacteriol (1968) 1.68

Albumin, fibrinogen and transferrin synthesis in isolated rat hepatocyte suspensions. A model for the study of plasma protein synthesis. Biochem J (1975) 1.66

A new assay of thymidylate synthetase activity based on the release of tritium from deoxyuridylate-5-3-H. J Biol Chem (1967) 1.64

HYDROXYMETHYLDEOXYCYTIDYLATE KINASE FORMATION AFTER BACTERIOPHAGE INFECTION OF ESCHERICHIA COLI. Proc Natl Acad Sci U S A (1959) 1.63

Critical issues in the management of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol (1995) 1.63

Medical students and history of medicine. J R Soc Med (1996) 1.59

Helicobacter pylori and HIV infection. Lancet (1990) 1.59

Routine cleaning and the elimination of Campylobacter pylori from endoscopic biopsy forceps. J Hosp Infect (1989) 1.57

Effect of neurotensin on gastric function in man. Lancet (1980) 1.55

Clarithromycin and omeprazole for Helicobacter pylori. Lancet (1992) 1.54

Eradication of Helicobacter pylori in patients with duodenal ulcer lowers basal and peak acid outputs to gastrin releasing peptide and pentagastrin. Gut (1996) 1.54

Prospective audit of perforation rates following upper gastrointestinal endoscopy in two regions of England. Br J Surg (1995) 1.53

Evidence for a possible direct role of dCMP hydroxymethylase in T4 phage DNA synthesis. Cold Spring Harb Symp Quant Biol (1968) 1.51

Lean body mass, gastric acid, and peptic ulcer. Gut (1969) 1.47

Metabolic studies in total parenteral nutrition with lipid in man. Comparison with glucose. J Clin Invest (1976) 1.45

Protein-sparing therapy in postoperative patients. Effects of added hypocaloric glucose or lipid. N Engl J Med (1976) 1.44

Direct participation of dCMP hydroxymethylase in synthesis of bacteriophage T4 DNA. Proc Natl Acad Sci U S A (1973) 1.44

Comparison of midazolam and diazepam in doses of comparable potency during gastroscopy. Br J Anaesth (1983) 1.40

Art in hospitals. Funding works of art in new hospitals. Br Med J (Clin Res Ed) (1985) 1.40

Total enteral nutrition support improves body composition of patients with active Crohn's disease. JPEN J Parenter Enteral Nutr (1995) 1.40

Cervical osteomyelitis and magnetic resonance imaging. J R Soc Med (1993) 1.39

Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet (1978) 1.39

Recurrence of duodenal ulcer after Helicobacter pylori eradication is related to high acid output. Aliment Pharmacol Ther (1997) 1.38

Detecting alcohol consumption as a cause of emergency general medical admissions. J R Soc Med (1986) 1.38

Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr (1977) 1.36

Metabolic studies, aldosterone secretion rate, and plasma renin after carbenoxolone sodium. Br Med J (1969) 1.32

Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease. Aliment Pharmacol Ther (2013) 1.32

Cardiac arrest after reversal of effects of opiates with naloxone. Br Med J (Clin Res Ed) (1984) 1.31

Celiac disease and spinocerebellar degeneration with normal vitamin E status. Neurology (1985) 1.28

Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses. J Immunol (1984) 1.28

Serum gastrin in duodenal ulcer. II. Effect of insulin hypoglycaemia. Gut (1971) 1.27

Midazolam and diazepam for gastroscopy. Anaesthesia (1982) 1.25

Upper gastrointestinal endoscopy in the elderly. Br Med J (Clin Res Ed) (1985) 1.23

Effect of the folic acid analogue, trimethoprim, on growth, macromolecular synthesis, and incorporation of exogenous thymine in Escherichia coli. J Bacteriol (1972) 1.23

Use of gastric function tests by British gastroenterologists. Br Med J (1971) 1.22

Letter: Montezuma's revenge. Lancet (1976) 1.21

Direct inhibition of gastric acid by growth-hormone release-inhibiting hormone in dogs. Lancet (1975) 1.20

Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg (1995) 1.20

Incorporation of fatty acids containing photosensitive groups into phospholipids of Escherichia coli. Proc Natl Acad Sci U S A (1976) 1.19

Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide. Dig Dis Sci (1983) 1.18

Loss of an essential function of Escherichia coli by deletions in the thyA region. J Bacteriol (1973) 1.17

Tetrahydrofolate-dependent labilization of the hydrogen atom on carbon 5 of 5'-deoxycytidylate, a step in the deoxycytidylate hydroxymethylase reaction. J Biol Chem (1967) 1.16

Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol). Gut (1986) 1.13

Campylobacter pyloridis in the upper gastrointestinal tract: a Brazilian study. Arq Gastroenterol (1988) 1.13

Galanin inhibits insulin secretion and induces hyperglycemia in dogs. Diabetes (1985) 1.12

Effects of supplemental oxygen on cardiac rhythm during upper gastrointestinal endoscopy: a randomised controlled double blind trial. Gut (1993) 1.10

Effect of total parenteral nutrition on gut hormone release in humans. Gastroenterology (1981) 1.10

Rice varieties with similar amylose content differ in starch digestibility and glycemic response in humans. Am J Clin Nutr (1991) 1.10

Relation between gastric acid output, Helicobacter pylori, and gastric metaplasia in the duodenal bulb. Gut (1996) 1.10

Total parenteral nutrition and complete bowel rest in the management of Crohn's disease. JPEN J Parenter Enteral Nutr (1985) 1.10

Regulation of deoxyribonucleotide biosynthesis during in vivo bacteriophage T4 DNA replication. Intrinsic control of synthesis of thymine and 5-hydroxymethylcytosine deoxyribonucleotides at precise ratio found in DNA. J Biol Chem (1977) 1.09

Vitamin C status in patients with acute pancreatitis. Br J Surg (1993) 1.09

Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Am J Gastroenterol (1988) 1.08

Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol (2001) 1.08

Characteristics of a bacteriophage T4-induced complex synthesizing deoxyribonucleotides. J Biol Chem (1982) 1.06

The Paterson-Brown Kelly syndrome of sideropenic dysphagia does not exist. J R Coll Physicians Lond (1991) 1.06

The role of blood flow in chronic duodenal ulcer. Scand J Gastroenterol (1996) 1.06

Electrodes for 24 hours pH monitoring--a comparative study. Gut (1987) 1.06

The discovery of gastric acid. Gastroenterology (1979) 1.05

Appropriate use of upper gastrointestinal endoscopy--a prospective audit. Steering Group of the Upper Gastrointestinal Endoscopy Audit Committee. Gut (1994) 1.05

Natural history of adhesional small bowel obstruction: counting the cost. Br J Surg (1998) 1.04

On the defect of a dCMP hydroxymethylase mutant of bacteriophage T4 showing enzyme activity in extracts. Biochem Biophys Res Commun (1973) 1.04

A temperature-sensitive thy mutant blocked in the synthesis of thymidylate synthetase. J Biol Chem (1971) 1.04

Simultaneous initiation of synthesis of bacteriophage T4 DNA and of deoxyribonucleotides. Proc Natl Acad Sci U S A (1976) 1.03

Breakdown of gastric mucus in presence of Helicobacter pylori. J Clin Pathol (1991) 1.03

Gastric output of pancreatic secretory trypsin inhibitor is increased by misoprostol. Gut (1991) 1.02

New dUTPase and dUDPase activites after infection of Escherichia coli by T2 bacteriophage. Proc Natl Acad Sci U S A (1966) 1.01

Effects of a moderate dose of alcohol on simulated laparoscopic surgical performance. Surg Endosc (2002) 1.01

Natural history and morphology of secretagogue-induced duodenal ulcers in rats. Gastroenterology (1975) 1.01

Eruptive tufted angiomas in a patient with Crohn's disease. J Clin Pathol (2005) 1.01

Protracted enteric cryptosporidial infection in selective immunoglobulin A and saccharomyces opsonin deficiencies. Gut (1990) 1.01

Peptic ulceration, gastric secretion, and renal transplantation. Br Med J (1977) 1.01

Effects of gastrointestinal hormones on fasting gallbladder storage patterns in man. Eur J Clin Invest (1979) 1.00